Clinical Trial – NANO SOMA

Clinically Observed Reported Effects

INPACTS CORE is a placebo-controlled, double-blind trial designed to determine the impact of oral Metadichol® – NANO SOMA® – on self-reported COVID-19-injection-related effects in those who have received injections and in their contacts who experience clinical issues they believe are related to “shedding”.

People all over the world report experiencing either new health problems or the worsening of existing ones after receiving COVID-19 injections or being in close contact with those who have. Options for assessing and relieving these conditions are almost non-existent, leaving many with a wide array of continuing, sometimes debilitating health issues impacting virtually every system of the body.

Metadichol – NANO SOMA – is a patented, non-toxic nutrient that, due to its unique mode of action, has been shown in patents and scientific publications to support health across a wide range of organs and systems.*

Using Metadichol – NANO SOMA – to give the body the information that it needs to address post-injection or post-injection shedding difficulties is a logical and potentially vital advancement in assisting those affected directly or indirectly by COVID-19 injections. The INPACTS CORE study aims to assess whether Metadichol – NANO SOMA – has a positive impact on the well-being of both the injected and their contacts. The study will examine the levels of comfort, health and well-being based on participants’ self-reported experiences – because no one knows your lived experience better than you do.

If you believe that you have health issues related to receiving COVID-19 injections or from being in contact with injected individuals and are interested in participating in a 2-week trial of a natural product to see if it improves your health, this study may be for you.

If you are experiencing health problems you believe developed or worsened following a COVID-19 injection, you may be eligible to join the INPACTS CORE study to evaluate the impact of a natural, patented nutritional substance on your post-injection issue(s).

Your information will be safeguarded to assure privacy and will be completely anonymized before publication or other dissemination. If selected, you will be asked to fill out a questionnaire detailing your COVID-19-injection history (administration of injection, lot number, manufacturer, etc.) or your contact with injected people, along with any changes in health or comfort levels following the injection or contact.

Participants will receive a supply of an oral spray to be used several times per day over a 2-week period. The spray may be either NANO SOMA (Metadichol) or a placebo. Neither the participants nor investigators will know who receives which version during the study – a design known as a “double-blind, placebo-controlled study.” The identity of each product will be revealed only after the study concludes.

At the end of the study, you will learn whether you were using the placebo or the active ingredient. All participants who complete the study will receive a 1-month supply of Metadichol – NANO SOMA – as a token of appreciation.

You will be asked to keep a detailed written log of your experiences, including the severity and frequency of a given experience. At the beginning of the study, you will also provide information such as your age, gender, health history, all medications and nutrients taken and other health information.

This information will be analyzed and published in anonymized form following standard scientific practice, ensuring your identity and personal information cannot be recognized.

NANO SOMA (Metadichol) is entirely non-toxic. It is derived from edible substances and can be taken by anyone at any life stage, although pregnant or nursing women and minors will not be enrolled. There are no known interactions between NANO SOMA (Metadichol) and medications, nutrients, food or water.

Some participants may have previously diagnosed health issues; others may have issues which have not received a medical name. In either case, if you are interested in participating and willing to follow the protocol and keep the symptom logs, you are welcome to apply. In addition, if you had a pre-existing issue which became worse after the COVID-19 injection(s), you are also welcome to apply.

There is no cost to participate, and while there is no financial compensation, those who complete the study will receive a 1-month supply of NANO SOMA (Metadichol) in gratitude.

If selected, you will be asked not to share your supply of product or discuss your experience with others during the trial, since people’s experiences vary widely and it is best not to suggest outcomes to other people in the study.

Participants include people above the age of 21 who are:

  • Experiencing discomfort or symptoms of new problems believed to have developed after receiving one or more COVID-19 injections, for which help has not been available or successful.
  • Experiencing an increased level of discomfort or symptoms in problems which were present before receiving one or more COVID-19 injections but which became worse after injection and for which help has not been either available or successful.
  • In close contact with one or more injected person(s), and who experienced newly developed problems after that person’s COVID-19 injection.
  • In close contact with one or more injected person(s), and who experienced a worsening of problems after that person’s COVID-19 injection.

People who should NOT participate in this study would include people who are:

  • Under the age of 21, pregnant or nursing
  • Unable or unwilling to keep accurate records of use of the study material and symptoms in the Participant Log several times a day
  • Uninterested in learning whether a simple nutrient might benefit their post injection or post contact difficulties
  • Not experiencing post-injection symptoms or the worsening of previous symptoms once the COVID-19 shots were received
  • Uncomfortable with the 50/50 chance of receiving a placebo instead of the active ingredient for the duration of the study. For these people, instructions on where to acquire the active NANO SOMA (Metadichol) product can be found at the end of this page.

To apply, complete the Initial Screening Document online. Once it has been reviewed, you will be notified whether a brief screening interview will be set up electronically with the Principal Investigator, Rima E. Laibow, MD.

In the screening interview, Dr. Laibow will go over the study protocol in detail, and you will have the opportunity to have your questions answered.

Participants from any part of the world are welcome. The study, logs, instructions, Informed Consent and other documents and conversations, assessments and meetings related to the study will be in English. Translation services are not available.

If you have been injected with COVID-19 products or have not been injected but are experiencing symptoms that you believe to be associated with the indirect impact of the COVID-19 injections, you are invited to submit an Initial Screening Interview form.

The duration of your participation in the study is 1 month. You will be asked to use an oral spray from a handy purse or pocket-sized vial several times a day and fill in a log containing a chart and a space for brief comments during that month.

At the end of that time, your data will be collected, anonymized and analyzed.  All participants will receive a copy of the final report, which we anticipate publishing in one or more scientific journals.

Your identity and medical data will remain confidential at all times.

The following is a set of notes and footnotes but not part of the protocol.

Bibliography and reference material (not yet organized, just noted here): Metadichol® Patents

NANO SOMA is made from all natural, food-based ingredients and have no known side effects. It is commonly called policosanol and is present in foods such as Rice, Sugarcane, Wheat etc.

The patented formula in NANO SOMA (Metadichol) represents an innovative modern breakthrough that supports immune function* at the cellular level. Formulated using nanotechnology as both a dietary supplement and as a topical solution, this incredible discovery (which comes from a powerful plant wax extracted from sugarcane) has been found to support many of the physiological functions essential for optimal skin and immune health.*

United States Patent 8,722,093 B2:, United States Patent 9,006,292 B2:, United States Patent 9,034,383 B2:

Bibliography: Studies

NANO SOMA is a nano emulsion of policosanols in liquid formulation. It has a particle size of below 50nm and can help to stimulate the immune system for maintenance of good health.* The primary ingredients in NANO SOMA are Policosanol from rice wax, vitamin E, and water.

NANO SOMA is made from all-natural food-based ingredients and has no known side effects.

NANO SOMA can be taken at any time of the day and with or without food and water.

There are no known interactions between NANO SOMA and prescription medications.

NANO SOMA is safe for children and infants.

4. https://patents.google.com/patent/US8722093B2/en

5. https://patents.google.com/patent/US9006292B2/en

6. https://patents.google.com/patent/US9034383

FDA Disclaimer :

* These statements have not been evaluated by the Food and Drugs Administration. This product is not intended to diagnose, treat, cure or prevent any disease.